First Eagle Investment Management LLC Grows Stock Holdings in LifeStance Health Group, Inc. (NASDAQ:LFST)

First Eagle Investment Management LLC grew its holdings in LifeStance Health Group, Inc. (NASDAQ:LFST) by 182.8% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 785,666 shares of the company’s stock after acquiring an additional 507,826 shares during the period. First Eagle Investment Management LLC owned about 0.21% of LifeStance Health Group worth $5,790,000 at the end of the most recent quarter.

Several other large investors have also made changes to their positions in LFST. Blue Trust Inc. boosted its holdings in shares of LifeStance Health Group by 124.4% in the 4th quarter. Blue Trust Inc. now owns 3,828 shares of the company’s stock valued at $27,000 after acquiring an additional 2,122 shares during the last quarter. Townsquare Capital LLC acquired a new position in shares of LifeStance Health Group in the 3rd quarter valued at $73,000. R Squared Ltd acquired a new position in shares of LifeStance Health Group in the 4th quarter valued at $80,000. Handelsbanken Fonder AB acquired a new position in shares of LifeStance Health Group in the 4th quarter valued at $128,000. Finally, Versor Investments LP acquired a new position in shares of LifeStance Health Group in the 4th quarter valued at $131,000. 85.50% of the stock is owned by hedge funds and other institutional investors.

LifeStance Health Group Stock Performance

NASDAQ:LFST opened at $6.92 on Friday. The company has a debt-to-equity ratio of 0.19, a quick ratio of 1.32 and a current ratio of 1.32. The company has a fifty day moving average of $7.80 and a two-hundred day moving average of $7.34. The stock has a market capitalization of $2.66 billion, a PE ratio of -26.62 and a beta of 1.27. LifeStance Health Group, Inc. has a fifty-two week low of $4.64 and a fifty-two week high of $8.61.

Analysts Set New Price Targets

LFST has been the subject of several analyst reports. The Goldman Sachs Group upgraded shares of LifeStance Health Group from a “neutral” rating to a “buy” rating and set a $10.00 target price for the company in a research note on Monday, December 16th. William Blair reiterated an “outperform” rating on shares of LifeStance Health Group in a research note on Friday, February 28th. One investment analyst has rated the stock with a sell rating, one has given a hold rating and three have given a buy rating to the company. According to MarketBeat, LifeStance Health Group presently has a consensus rating of “Hold” and a consensus target price of $8.63.

About LifeStance Health Group

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.